PT  - JOURNAL ARTICLE
AU  - Xinhai Li
AU  - Xumao Zhao
AU  - Yuehua Sun
TI  - The lockdown of Hubei Province causing different transmission dynamics of the novel coronavirus (2019-nCoV) in Wuhan and Beijing
AID  - 10.1101/2020.02.09.20021477
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.02.09.20021477
4099  - http://medrxiv.org/content/early/2020/02/17/2020.02.09.20021477.short
4100  - http://medrxiv.org/content/early/2020/02/17/2020.02.09.20021477.full
AB  - Background After the outbreak of novel coronavirus (2019-nCoV) starting in late 2019, a number of researchers have reported the predicted the virus transmission dynamics. However, under the strict control policy the novel coronavirus does not spread naturally outside Hubei Province, and none of the prediction closes to the real situation.Methods and findings We used the traditional SEIR model, fully estimated the effect of control measures, to predict the virus transmission in Wuhan, the capital city of Hubei Province, and Beijing. We forecast that the outbreak of 2019-nCoV would reach its peak around March 6±10 in Wuhan and March 20±16 in Beijing, respectively. The infectious population in Beijing would be much less (only 0.3%) than those in Wuhan at the peak of this transmission wave. The number of confirmed cases in cities inside Hubei Province grow exponentially, whereas those in cities outside the province increase linearly.Conclusions The unprecedented province lockdown substantially suspends the national and global outbreak of 2019-nCoV.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNone.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesTo make our analysis repeatable, we posted all the data used in this study and R code for the SEIR model at the Github server. https://github.com/Xinhai-Li/2019-nCoV.